LOVFF
Price
$1.29
Change
+$0.02 (+1.57%)
Updated
Feb 3 closing price
Capitalization
126.76M
Intraday BUY SELL Signals
VTRS
Price
$14.34
Change
+$0.66 (+4.82%)
Updated
Feb 4, 03:26 PM (EDT)
Capitalization
15.76B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LOVFF vs VTRS

Header iconLOVFF vs VTRS Comparison
Open Charts LOVFF vs VTRSBanner chart's image
Cannara Biotech
Price$1.29
Change+$0.02 (+1.57%)
Volume$25.03K
Capitalization126.76M
Viatris
Price$14.34
Change+$0.66 (+4.82%)
Volume$3.58K
Capitalization15.76B
LOVFF vs VTRS Comparison Chart in %
LOVFF
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LOVFF vs. VTRS commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LOVFF is a Hold and VTRS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LOVFF: $1.29 vs. VTRS: $13.68)
Brand notoriety: LOVFF and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LOVFF: 331% vs. VTRS: 105%
Market capitalization -- LOVFF: $126.76M vs. VTRS: $15.76B
LOVFF [@Pharmaceuticals: Generic] is valued at $126.76M. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $15.76B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LOVFF’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 3 green FA rating(s).

  • LOVFF’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 3 green, 2 red.
According to our system of comparison, VTRS is a better buy in the long-term than LOVFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LOVFF’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • LOVFF’s TA Score: 3 bullish, 5 bearish.
  • VTRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than LOVFF.

Price Growth

LOVFF (@Pharmaceuticals: Generic) experienced а -2.31% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.83%. For the same industry, the average monthly price growth was -2.35%, and the average quarterly price growth was +12.98%.

Reported Earning Dates

VTRS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.83% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($15.8B) has a higher market cap than LOVFF($127M). VTRS has higher P/E ratio than LOVFF: VTRS (236.20) vs LOVFF (14.72). VTRS YTD gains are higher at: 9.880 vs. LOVFF (1.732). LOVFF has higher annual earnings (EBITDA): 27M vs. VTRS (-598.9M). VTRS has more cash in the bank: 1.16B vs. LOVFF (14.4M). LOVFF has less debt than VTRS: LOVFF (47.5M) vs VTRS (14.7B). VTRS has higher revenues than LOVFF: VTRS (14.1B) vs LOVFF (102M).
LOVFFVTRSLOVFF / VTRS
Capitalization127M15.8B1%
EBITDA27M-598.9M-5%
Gain YTD1.7329.88018%
P/E Ratio14.72236.206%
Revenue102M14.1B1%
Total Cash14.4M1.16B1%
Total Debt47.5M14.7B0%
FUNDAMENTALS RATINGS
LOVFF vs VTRS: Fundamental Ratings
LOVFF
VTRS
OUTLOOK RATING
1..100
9284
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
13
Undervalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
5096
PRICE GROWTH RATING
1..100
526
P/E GROWTH RATING
1..100
401
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (13) in the null industry is somewhat better than the same rating for LOVFF (57). This means that VTRS’s stock grew somewhat faster than LOVFF’s over the last 12 months.

LOVFF's Profit vs Risk Rating (67) in the null industry is somewhat better than the same rating for VTRS (100). This means that LOVFF’s stock grew somewhat faster than VTRS’s over the last 12 months.

LOVFF's SMR Rating (50) in the null industry is somewhat better than the same rating for VTRS (96). This means that LOVFF’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's Price Growth Rating (6) in the null industry is somewhat better than the same rating for LOVFF (52). This means that VTRS’s stock grew somewhat faster than LOVFF’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for LOVFF (40). This means that VTRS’s stock grew somewhat faster than LOVFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LOVFFVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 8 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
LOVFF
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ILKAF3.700.09
+2.49%
Iluka Resources Ltd.
MQBKY152.342.81
+1.88%
Macquarie Group, Ltd.
ZLDSF30.50N/A
N/A
ZALANDO SE
SPXXF13.76N/A
N/A
Sparebanken Nord Norge
PRPS1.40-0.10
-6.67%
PROPELLUS INC.

LOVFF and

Correlation & Price change

A.I.dvisor tells us that LOVFF and KKPCF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LOVFF and KKPCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LOVFF
1D Price
Change %
LOVFF100%
+3.78%
KKPCF - LOVFF
6%
Poorly correlated
N/A
VTRS - LOVFF
3%
Poorly correlated
N/A
VEXTF - LOVFF
1%
Poorly correlated
-5.76%
GEDSF - LOVFF
-0%
Poorly correlated
N/A
IMCC - LOVFF
-0%
Poorly correlated
-5.47%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with AMRX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
N/A
AMRX - VTRS
50%
Loosely correlated
+0.42%
ELAN - VTRS
48%
Loosely correlated
-1.62%
AMPH - VTRS
45%
Loosely correlated
+1.15%
EBS - VTRS
43%
Loosely correlated
-1.45%
ZTS - VTRS
38%
Loosely correlated
-2.02%
More